Editas, Intellia: After Big Sell Off, Is it Time To Buy Gene Editing Stocks?

Get the Full StoryOur indicative theme of Gene Editing stocks is down by about 24 year-to-date, compared to the S&P 500 which has remained almost flat over the same period. The recent sell-off comes on the back of rising bond yields, which have caused investors to rotate out of technology and other growth stocks...

Share: